Weaker Buy Today AMPH ranks #13 as BUY CANDIDATE. Stronger Buy
Today AMPH ranks #13 as BUY CANDIDATE.

AMPH stock Amphastar Pharmaceuticals

AMPH stock
Amphastar Pharmaceuticals

22 January 2019
Change 2.05%
Chart period: 2018-10-23 - 2019-01-22
VOLUME
Buy
TREND
Buy

MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Buy
Request Prediction
Predict

Amphastar Pharmaceuticals Stock Analysis

Technical stock analysis for 22 January 2019

Buy candidate since 2019-01-04 Gain 8.53%
Shorts n/a
Cash n/a
Loans n/a
Beta 1.38
ROA -1.30

Amphastar Pharmaceuticals gained 2.05% in the last trading day, rising from $21.94 to $22.39 The price has risen in 7 of the last 10 days and is up by 7.96% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 127 408 more shares were traded than the day before. In total, 231 897 shares bought and sold for approximately $5.19 million.

Close price at the end of the last trading day (Tuesday, 22nd Jan 2019) of the AMPH stock was $22.39. This is 2.05% more than the trading day before Friday, 18th Jan 2019.

During day the stock fluctuated 3.40% from a day low at $21.76 to a day high of $22.50.

30 day high of the AMPH stock price was $22.50 and low was $18.89.
90 day high was $22.74 and low was $17.71.
52 week high for the Amphastar Pharmaceuticals - $22.74 and low - $14.40.

Trend

Amphastar Pharmaceuticals lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 12.65% during the next 3 months and, with 90% probability hold a price between $22.36 and $26.97 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Only positive signals in the chart today. Amphastar Pharmaceuticals holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $21.93 and $20.94. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday January 14, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock holds a RSI14 at 73 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

Amphastar Pharmaceuticals finds support from accumulated volume at $21.72.

Support: $21.72 Price: $22.39 Resistance: $22.51

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.74 between high and low, or 3.40%. For the last week, the stock has had a daily average volatility of 2.80%.

Our recommended stoploss: $21.36 (-4.59%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 73 and this increases the risk substantially. There is a buy signal from pivot bottom found 5 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation

Amphastar Pharmaceuticals holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Strong Buy Candidate.

Weaker Buy Today AMPH ranks #13 as BUY CANDIDATE. Stronger Buy
Today AMPH ranks #13 as BUY CANDIDATE.